EQL PHARMA AB revenue for the last year amounted to 260.00 M SEK, the most of which — 203.78 M SEK — came from its highest performing source at the moment, Drug, the year earlier bringing 135.36 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought EQL PHARMA AB 162.77 M SEK, and the year before that — 409.75 M SEK.